Elixir Medical touts live case for DeSolve NXT Plus BRS
Elixir Medical touted a live case demonstration of its DeSolve NXT Plus novolimus-eluting bioresorbable scaffold at the conference.
“This live demonstration presented a case of a 51-year-old diabetic patient with complex multi-vessel disease involving a long fibrotic lesion. Elixir’s DeSolve NXT Plus had excellent visibility, smooth deliverability and DES-like inflation that enabled me to treat the diseased artery with ease and confidence,” said Dr. Stefan Verheye, of Antwerp’s ZNA Middleheim, who performed the procedure in Belgium, from where it was streamed live to the TCT event. “I’m pleased to report that the acute outcome of the procedure was successful, and the patient is doing well.”
“The successful live case demonstration of Elixir’s DeSolve NXT Plus system at TCT reinforces our commitment to providing cardiologists with state-of-the-art bioresorbable scaffold products that match the excellent deliverability and enhanced conformability of market-leading coronary drug eluting stents to ensure their greater adoption in everyday clinical practice,” added CEO Motasim Sirhan. “Moreover, Elixir will be able to leverage the novel Transform balloon technology across all our scaffold platforms making Elixir’s bioresorbable scaffold portfolio the broadest and most innovative in the world.”
